Pancreatoblastoma is a rarely occurring malignant tumor in childhood, which has been reported less 60cases in the world. which is a kind of adenocarcinoma exhibiting solid encapsulating tumor. Its prognosis is better favorable than typical pancreatic cancer. We were experienced one case of pancreatoblastoma, the patient was a 8 years-old boy who was incidentally found by his parent because of left upper quadrant mass during having a bath without any previous medical history. His preoperative AFP level was elevated and his preoperative diagnosis was pancreatoblastoma by abdominal computed tomography. During laparotomy, the tumor was located between body and tail of pancreas, adhered to hilum of spleen and also surrounded by transverse mesocolon, displacing the arcade of mesocolic vessels. When dissecting the mesocolon from pancreatic tumor, superior mesenteric artery and gastroduodenal artery were embeded in the tumor. The patient underwent distal pancreatectomy and splenectomy after ligature and dividing of mid-colic vessel. After surgery, he was received six-cycle of combined chemotherapy. There is no evidence of recurrence and metastasis for nineteen months after surgery.
Adenocarcinoma ; Arteries ; Baths ; Child ; Diagnosis ; Drug Therapy ; Humans ; Laparotomy ; Ligation ; Male ; Mesenteric Artery, Superior ; Mesocolon ; Neoplasm Metastasis ; Pancreas ; Pancreatectomy ; Pancreatic Neoplasms ; Parents ; Prognosis ; Recurrence ; Spleen ; Splenectomy

PURPOSE: To evaluate the efficacy of sclerotherapy with OK-432 for lymphangiomas. MATERIALS AND METHODS: Retrospective review of twelve patients with lymphangiomas who were treated with OK-432 from 1996 to 2000. RESULTS: Twelve patients were treated by sclerotherapy with OK-432. Ten patients were received sclerotherapy with OK-432 as primary therapy, and two were treated as secondary therapy after failure of surgery. Six cases were cystic hygroma (macrocystic); all of them, complete shrinkage was obtained. The other six cases were cavernous lymphangioma (microcystic): two of them, therapy were successful, but four were failed to achieve satisfactory shrinkage. So, they underwent surgical excision after failure of sclerotherapy. The results were excellent in cystic hygroma (success rate; 100%), however moderately poor results were obtained in cavernous lymphangioma (success rate 33.3%). CONCLUSION: Intralesional injection of OK-432 is effective therapy for cystic hygroma as a primary therapy.
Humans ; Injections, Intralesional ; Lymphangioma* ; Lymphangioma, Cystic ; Picibanil* ; Retrospective Studies ; Sclerotherapy